The federal government has
confirmed the investment of more
than $600 million to support over
800 innovative medical research
projects conducted by 2,200
Australian scientists.
Research into obesity prevention,
cancer genomics and hereditary
diseases are included, along with a
new medication to treat severe ice
addiction and new treatments for
drug-resistant depression.
The ice addiction project will look
at lisdexamphetamine, a substitute
for methamphetamine in a clinical
trial of around 240 people heavily
dependent on ice over a four year
period.
There’s also a project looking at
post-traumatic symptom disorder
and new research to establish a link
between shift work and pregnancy
outcomes, according to health
minister Sussan Ley.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Nov 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Nov 15
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.